Literature DB >> 7370063

Penicillamine-induced myasthenia gravis in progressive systemic sclerosis.

C F Torres, R C Griggs, J Baum, A S Penn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7370063     DOI: 10.1002/art.1780230414

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  5 in total

1.  An Update on the Treatment of the Cutaneous Manifestations of Systemic Sclerosis: The Dermatologist's Point of View.

Authors:  Magalys Vitiello; Adriana Abuchar; Néstor Santana; Luis Dehesa; Francisco A Kerdel
Journal:  J Clin Aesthet Dermatol       Date:  2012-07

2.  D-penicillamine induced myasthenia gravis in rheumatoid arthritis: an unpredictable common occurrence?

Authors:  A P Andonopoulos; E Terzis; E Tsibri; C A Papasteriades; T Papapetropoulos
Journal:  Clin Rheumatol       Date:  1994-12       Impact factor: 2.980

Review 3.  Penicillamine in rheumatoid arthritis. A problem of toxicity.

Authors:  H G Taylor; A Samanta
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

4.  Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features.

Authors:  J P Delamere; S Jobson; L P Mackintosh; L Wells; K W Walton
Journal:  Ann Rheum Dis       Date:  1983-10       Impact factor: 19.103

5.  HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.

Authors:  M J Garlepp; R L Dawkins; F T Christiansen
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.